Evidence map›Paper›PMID 32503496›Full record

SynthesisBMC nephrology2020

The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature.

Jordan Stanford, Karen Charlton, Anita Stefoska-Needham, Rukayat Ibrahim, Kelly Lambert

Registry-linked trialOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05081960 (Evaluating the Vitamin K2 Status of Calcium-based Stone Formers), which is not on this map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05081960 completednot on this mapstarted 2022, after this paper: background citation

Evaluating the Vitamin K2 Status of Calcium-based Stone Formers

TypeobservationalSponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sRan2022 to 2025Enrolled60ConditionsKidney Calculi, Calcium Oxalate Kidney Stones, Vitamin K 2, Human
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. The gut as a central hub for multi-organ crosstalk in aging.Cellular and molecular life sciences : CMLS · 2026
    Review
  10. Frontiers in pharmacology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Microbiota and kidney disease: the road ahead.Nature reviews. Nephrology · 2025
    Review
  16. Anti-Anaerobic Antibiotics, Gut Microbiota, and Sepsis-associated Acute Kidney Injury.American journal of respiratory and critical care medicine · 2025
    Article
  17. Gut Microbiome as a Risk Factor for Future CKD.Kidney international reports · 2025
    Article
  18. Article
  19. The role of the intestinal microbiome in cognitive decline in patients with kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jordan StanfordUniversity of Wollongong, School of Medicine, Faculty of Science, Medicine and Health, Wollongong, New South Wales, 2522, Australia. js096@uowmail.edu.au.
Karen CharltonUniversity of Wollongong, School of Medicine, Faculty of Science, Medicine and Health, Wollongong, New South Wales, 2522, Australia.
Anita Stefoska-NeedhamUniversity of Wollongong, School of Medicine, Faculty of Science, Medicine and Health, Wollongong, New South Wales, 2522, Australia.
Rukayat IbrahimUniversity of Surrey, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, Guildford, GU2 7XH, UK.
Kelly LambertUniversity of Wollongong, School of Medicine, Faculty of Science, Medicine and Health, Wollongong, New South Wales, 2522, Australia.
University of Wollongong · AUUniversity of Surrey · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is mounting evidence that individuals with kidney disease and kidney stones have an abnormal gut microbiota composition. No studies to date have summarised the evidence to categorise how the gut microbiota profile of these individuals may differ from controls. Synthesis of this evidence is essential to inform future clinical trials. This systematic review aims to characterise differences of the gut microbial community in adults with kidney disease and kidney stones, as well as to describe the functional capacity of the gut microbiota and reporting of diet as a confounder in these studies.

methodsIncluded studies were those that investigated the gut microbial community in adults with kidney disease or kidney stones and compared this to the profile of controls. Six scientific databases (CINHAL, Medline, PubMed, Scopus, Web of Science and Cochrane Library), as well as selected grey literature sources, were searched. Quality assessment was undertaken independently by three authors. The system of evidence level criteria was employed to quantitatively evaluate the alteration of microbiota by strictly considering the number, methodological quality and consistency of the findings. Additional findings relating to altered functions of the gut microbiota, dietary intakes and dietary methodologies used were qualitatively summarised.

resultsTwenty-five articles met the eligibility criteria and included data from a total of 892 adults with kidney disease or kidney stones and 1400 controls. Compared to controls, adults with kidney disease had increased abundances of several microbes including Enterobacteriaceae, Streptococcaceae, Streptococcus and decreased abundances of Prevotellaceae, Prevotella, Prevotella 9 and Roseburia among other taxa. Adults with kidney stones also had an altered microbial composition with variations to Bacteroides, Lachnospiraceae NK4A136 group, Ruminiclostridium 5 group, Dorea, Enterobacter, Christensenellaceae and its genus Christensenellaceae R7 group. Differences in the functional potential of the microbial community between controls and adults with kidney disease or kidney stones were also identified. Only three of the 25 articles presented dietary data, and of these studies, only two used a valid dietary assessment method.

conclusionsThe gut microbiota profile of adults with kidney disease and kidney stones differs from controls. Future study designs should include adequate reporting of important confounders such as dietary intake to assist with interpretation of findings.

Indexed as

Gastrointestinal MicrobiomeAdultCase-Control StudiesHumansKidney CalculiKidney DiseasesDiet therapyGastrointestinal microbiomeKidney diseasesNephrolithiasisSystematic review

Identifiers

PMID32503496
PMCPMC7275316
OpenAlexW3033316454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.